Related Experiment Video

Updated: Nov 16, 2025

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
07:27

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis

Published on: February 24, 2023

3.5K

Malawian children with fast-breathing pneumonia with and without comorbidities

Amy Sarah Ginsburg1, Tisungane Mvalo2, Jun Hwang3

  • 1University of Washington Clinical Trial Center, Building 29, Suite 250, 6200 NE 74th Street, Seattle, WA, 98115, USA. messageforamy@gmail.com.

Pneumonia (Nathan Qld.)
|February 25, 2021
PubMed

Insights

Children with fast-breathing pneumonia and comorbidities, often excluded from trials, showed similar cure rates to those without comorbidities. Early risk assessment and treatment are key for successful outcomes in high-risk pediatric pneumonia cases.

Area of Science:

  • Pediatric infectious diseases
  • Clinical trial methodology
  • Global health

Background:

  • Children with comorbidities are often excluded from pneumonia treatment trials due to high mortality risk.
  • Understanding outcome heterogeneity in pediatric pneumonia with comorbidities is crucial for effective treatment.
  • A concurrent randomized controlled trial (RCT) and observational study were conducted in Malawi.

Purpose of the Study:

  • To compare clinical cure rates at Day 14 for children with fast-breathing pneumonia and comorbidities versus those without comorbidities.
  • To evaluate if children with comorbidities excluded from an RCT fared worse than those included.

Main Methods:

  • A prospective observational study was conducted alongside a randomized controlled trial (RCT) in Lilongwe, Malawi.
  • Comorbidities included HIV infection/exposure, malaria, severe acute malnutrition, and anemia.
  • Clinical cure at Day 14 was assessed in children with and without comorbidities.

Main Results:

  • Among 79 children in the observational cohort, common comorbidities were HIV (72.2%), malaria (25.3%), and anemia (21.5%).
  • Treatment failure rates were not significantly different between children with (4.1%) and without (4.5%) comorbidities.
  • Clinical cure rates by Day 14 were similar: 95.8% with comorbidities vs. 96.7% without.

Conclusions:

  • Children with fast-breathing pneumonia and comorbidities excluded from the RCT did not have worse outcomes.
  • Appropriate risk assessment and treatment can lead to clinical cure by Day 14 in high-risk children.
  • Early care-seeking by caregivers and timely interventions are vital for pediatric pneumonia management.
Abstract

Keywords:
AfricaCommunity-acquired pneumoniaComorbidityFast-breathing

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.2K
Breath Collection from Children for Disease Biomarker Discovery06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.2K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
580
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
494
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
573
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
271